U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

The FDA Drug Shortage database is currently experiencing technical difficulties and some of the information contained in the database may not reflect the current supply status.

Start Over | Back to Previous Screen

Adenosine Injection
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Expand all

Hospira (New 06/28/2022)

Company Contact Information:
844-646-4398

Presentation Posting Date Related Information
90 mg/30 mL (3 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-1932-02) N/A

Teva (New 08/11/2022)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
NDC 0703-8776-01 (60 mg/20 mL (3 mg/mL)) 08/11/2022 Product is currently unavailable and no future production expected for an extended period.
NDC 0703-8777-01 (90 mg/30 mL (3 mg/mL)) 08/11/2022 Product is available with an expected supply duration until JUL 2022. No future production expected for an extended period.
Back to Top